Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 25.71 USD 0.27% Market Closed
Market Cap: 1.2B USD

Intrinsic Value

The intrinsic value of one AMPH stock under the Base Case scenario is 43.54 USD. Compared to the current market price of 25.71 USD, Amphastar Pharmaceuticals Inc is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMPH Intrinsic Value
43.54 USD
Undervaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Amphastar Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for AMPH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Amphastar Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amphastar Pharmaceuticals Inc

Current Assets 588m
Cash & Short-Term Investments 236.9m
Receivables 145.4m
Other Current Assets 205.7m
Non-Current Assets 1B
Long-Term Investments 5.9m
PP&E 353.8m
Intangibles 584.5m
Other Non-Current Assets 94.1m
Efficiency

Free Cash Flow Analysis
Amphastar Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Amphastar Pharmaceuticals Inc

Revenue
730.7m USD
Cost of Revenue
-361.7m USD
Gross Profit
369m USD
Operating Expenses
-174.3m USD
Operating Income
194.7m USD
Other Expenses
-53.1m USD
Net Income
141.6m USD
Fundamental Scores

AMPH Profitability Score
Profitability Due Diligence

Amphastar Pharmaceuticals Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
64/100
Profitability
Score

Amphastar Pharmaceuticals Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

AMPH Solvency Score
Solvency Due Diligence

Amphastar Pharmaceuticals Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
52/100
Solvency
Score

Amphastar Pharmaceuticals Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc

Wall Street analysts forecast AMPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMPH is 35.96 USD with a low forecast of 31.31 USD and a high forecast of 42 USD.

Lowest
Price Target
31.31 USD
22% Upside
Average
Price Target
35.96 USD
40% Upside
Highest
Price Target
42 USD
63% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Amphastar Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AMPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AMPH Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AMPH stock?

The intrinsic value of one AMPH stock under the Base Case scenario is 43.54 USD.

Is AMPH stock undervalued or overvalued?

Compared to the current market price of 25.71 USD, Amphastar Pharmaceuticals Inc is Undervalued by 41%.

Back to Top